Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Foslinanib Sodium (TRX818 Sodium) is an anticancer compound.It inhibits vasculogenic mimicry network formation in C8161 and SK-MEL-28 melanoma cells when used at concentrations ranging from less than or equal to 5 to 10 nM
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 46,500 |
5 mg | 在庫あり | ¥ 94,500 |
10 mg | 在庫あり | ¥ 141,000 |
25 mg | 在庫あり | ¥ 224,500 |
50 mg | 在庫あり | ¥ 303,000 |
100 mg | 在庫あり | ¥ 408,500 |
説明 | Foslinanib Sodium (TRX818 Sodium) is an anticancer compound.It inhibits vasculogenic mimicry network formation in C8161 and SK-MEL-28 melanoma cells when used at concentrations ranging from less than or equal to 5 to 10 nM |
別名 | TRX818 Sodium |
分子量 | 409.21 |
分子式 | C16H11FNNa2O6P |
CAS No. | 1256037-62-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 7.86 mg/mL (19.2 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Foslinanib Sodium 1256037-62-3 Others TRX818 Sodium Inhibitor inhibitor inhibit